Evidence map›Paper›PMID 28317944›Full record

ArticleScientific reports2017

Inferring biomarkers for Mycobacterium avium subsp. paratuberculosis infection and disease progression in cattle using experimental data.

Gesham Magombedze, Tinevimbo Shiri, Shigetoshi Eda, Judy R Stabel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Use of ELISA to predict highJournal of veterinary research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Development of a Method to DetectFrontiers in veterinary science · 2021
    Article
  8. Article
  9. Cells · 2020
    Article
  10. Article
  11. Article
  12. EnvironmentalFrontiers in cellular and infection microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Gesham MagombedzeCenter for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
Tinevimbo ShiriWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
Shigetoshi EdaNational Institute for Mathematical and Biological Synthesis, University of Tennessee, Volunteer Blvd, Suite 106, Knoxville, TN, 37996, USA.
Judy R StabelUSDA-ARS, National Animal Disease, Ames, IA 50010, USA.
Baylor University Medical Center · USNational Animal Disease Center · USUniversity of Tennessee at Knoxville · USUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Available diagnostic assays for Mycobacterium avium subsp. paratuberculosis (MAP) have poor sensitivities and cannot detect early stages of infection, therefore, there is need to find new diagnostic markers for early infection detection and disease stages. We analyzed longitudinal IFN-γ, ELISA-antibody and fecal shedding experimental sensitivity scores for MAP infection detection and disease progression. We used both statistical methods and dynamic mathematical models to (i) evaluate the empirical assays (ii) infer and explain biological mechanisms that affect the time evolution of the biomarkers, and (iii) predict disease stages of 57 animals that were naturally infected with MAP. This analysis confirms that the fecal test is the best marker for disease progression and illustrates that Th1/Th2 (IFN-γ/ELISA antibodies) assays are important for infection detection, but cannot reliably predict persistent infections. Our results show that the theoretical simulated macrophage-based assay is a potential good diagnostic marker for MAP persistent infections and predictor of disease specific stages. We therefore recommend specifically designed experiments to test the use of a based assay in the diagnosis of MAP infections.

Indexed as

Disease ProgressionAnimalsBiological AssayBiomarkersCattleCattle DiseasesFecesInterferon-gammaKineticsMacrophagesModels, BiologicalMycobacterium avium subsp. paratuberculosisParatuberculosisTh1 CellsTh2 CellsBiomarkersInterferon-gamma

Identifiers

PMID28317944
PMCPMC5357903
OpenAlexW2603824155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.